Endogenous regulation of inflammatory pain by T-cell-derived opioids: when friend turns to foe.

Lilian Basso, Jérôme Boué, Arnaud Bourreille, Gilles Dietrich

Journal: Inflammatory bowel diseases 2015;20(10):1870-7

PMID: 24846722

Abstract

Painful sensation is a hallmark of microbe-induced inflammation. This inflammatory pain is downregulated a few days after infection by opioids locally released by effector T lymphocytes generated in response to microbe-derived antigens. This review focuses on the endogenous regulation of inflammatory pain associated with adaptive T-cell response and puts in perspective the clinical consequences of the opioid-mediated analgesic activity of colitogenic T lymphocytes in inflammatory bowel disease.

Address: *INSERM, Unit 1043, Toulouse, France; †CNRS, Unit 5282, Toulouse, France; ‡Centre de Physiopathologie de Toulouse Purpan, Université de Toulouse, UPS, Toulouse, France; §INSERM, Unit 913, Nantes, France; and ‖Institut des Maladies de l'Appareil Digestif, Université de Nantes, Nantes, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.